Atlas Trials

A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS

Clinical trial NCT05456269 · WITHDRAWN

Trial details

NCT number
NCT05456269
Sponsor
Racura Oncology Ltd
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaHigher Risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
Start date
2022-07-29
Primary completion
2023-08-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.